^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
HepatoPredict

Company:
Ophiomics
Type:
CE Marked

Details

Evidence
HepatoPredict is an in vitro diagnostic test that supports the clinical decision of liver transplantation in hepatocellular carcinoma (HCC). A molecular signature is integrated with clinical parameters into a predictive algorithm that estimates the risk of HCC recurrence after a liver transplant. It is based on a gene expression signature, measured by a real-time PCR assay, of 4 target genes and 3 housekeeping genes, and clinical parameters combined into a computational algorithm, that can predict the good outcome of the intervention with a successful-curative rate of 92.
Cancer:
Hepatocellular Cancer
Method:
RT-PCR
Approvals
Date
Cancer
Gene
Drug
By
10/10/22
CE